Comparison of Urinary Biomarkers in Diagnosis of Ureteropelvic Junction Obstruction and Differentiation from Nonobstructive Dilatation
Sangeetha Geminiganesan, Ashwin Raj Kumar, S. Kumaravel, C. D. Mohana Priya, Sathyamurthy Arunaa, Ramesh Babu- Surgery
- Pediatrics, Perinatology and Child Health
ABSTRACT
Background and Aims:
Differentiation of nonobstructive dilatation (NOD) from ureteropelvic junction obstruction (UPJO) is a challenge in children with antenatally detected hydronephrosis. The aim of this study is to compare the utility of urinary biomarkers: carbohydrate antigen (CA 19-9), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule (KIM) in diagnosing UPJO.
Methods:
A prospective study was conducted after obtaining ethical clearance between 2021 and 2022. Group 1 – control group (
Results:
The urine CA 19-9 level was 128.05 ± 4.08 U/mL in the UPJO group, and this was significantly higher (
Conclusions:
CA 19-9 is a superior marker compared to NGAL and KIM in differentiating UPJO from NOD. Further studies with larger numbers are warranted.